31st Mar 2023
Interim results to 31 December 2022
genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces unaudited i...
30th Mar 2023
Genedrive® MT-RNR1 ID Test receives positive final recommendation by NICE
NICE issues final guidance for use in the NHS through Early Value Assessment programme...
20th Mar 2023
Genedrive® MT-RNR1 to commence roll out in Greater Manchester
genedrive plc (AIM:GDR), the point of care molecular diagnostics company, announces that the Ge...